Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sato Vicki L
Relationship:  
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   1,672,571    

Indirect Shares

   8,084      
Direct Value   $38,302,611    

Indirect Value

   $3,385,741      
Total Shares   1,680,655      
Total Value   $41,688,352      


Vertex Pharmaceuticals Inc $32,346,725 Perkinelmer Inc $3,081,815 Infinity Pharmaceuticals Inc $0 Borgwarner Inc $643,058 Denali Therapeutics Inc. $2,231,013 Vir Biotechnology, Inc. $0 Allogene Therapeutics, Inc. $0 Vertex Pharmaceuticals Inc $32,346,725 Perkinelmer Inc $3,081,815 Infinity Pharmaceuticals Inc $0 Borgwarner Inc $643,058 Denali Therapeutics Inc. $2,231,013 Vir Biotechnology, Inc. $0 Allogene Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX President 2005-05-11 77,233 2005-05-11 8,084    Premium*  
            Perkinelmer Inc PKI Director 2017-02-09 29,970 2004-04-27 0    Premium*  
            Infinity Pharmaceuticals Inc INFI Director 2006-09-12 11,051 2006-09-12 0    Premium*  
            Borgwarner Inc BWA Director 2020-04-29 19,823 2014-04-30 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2024-04-15 118,043 2017-12-12 0    Premium*  
            Vir Biotechnology, Inc. VIR Director 2023-06-30 1,315,351 0    Premium*  
            Allogene Therapeutics, Inc. ALLO 2023-06-13 101,100 2021-07-30 0    Premium*  
* Premium Members only  

Records found :    226         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 10
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... President   •       –      –    2004-12-22 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2004-12-29 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2005-01-12 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2005-01-19 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2005-01-26 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2005-02-02 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2005-02-09 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2005-02-16 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2005-02-23 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2005-03-02 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2005-05-11 4 OE $9.50 $66,500 D/D 7,000 115,108 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2004-01-14 4 AS $9.62 $36,556 D/D (3,800) 116,917 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2004-09-22 4 AS $10.17 $71,190 D/D (7,000) 117,617 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2024-04-15 4 AS $18.29 $30,471 D/D (1,666) 118,043 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2024-03-15 4 AS $20.10 $33,487 D/D (1,666) 119,709 0 %
VRTX Vertex Pharmaceuticals In... President   •       –      –    2004-01-07 4 AS $10.07 $38,266 D/D (3,800) 120,717 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2024-02-15 4 AS $18.37 $30,604 D/D (1,666) 121,375 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2024-01-16 4 AS $18.42 $30,688 D/D (1,666) 123,041 0 %
VRTX Vertex Pharmaceuticals In... President   •       –      –    2003-12-31 4 AS $10.19 $38,722 D/D (3,800) 124,517 -
VRTX Vertex Pharmaceuticals In... President   •       –      –    2004-09-15 4 AS $10.11 $70,770 D/D (7,000) 124,617 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-12-15 4 AS $23.39 $38,968 D/D (1,666) 124,707 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-11-10 4 AS $52.49 $87,983 D/D (1,666) 126,167 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-11-15 4 AS $19.13 $31,871 D/D (1,666) 126,373 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2021-11-01 4 AS $50.05 $83,383 D/D (1,666) 127,833 0 %
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-10-16 4 AS $20.66 $34,420 D/D (1,666) 128,039 0 %
  226  Records found
  1   2   3   4   5   6  7   8   9   10      
  Page 6 of 10  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us